Crossmark

The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study

Published Online: 2018-11-30

Published Print: 2018-12

Authors

Mazdeh, Mehrdokht

Hosseini, Shno

Taheri, Mohammad https://orcid.org/0000-0001-8381-0591
Ghafouri‐Fard, Soudeh
Funding

Funding for this research was provided by:

Hamadan University of Medical Sciences
License Information

Version of Record valid from 2018-11-30

Text and Data Mining valid from 2018-11-30
More Information

Article History

Received: 26 October 2018

Accepted: 14 November 2018

First Online: 30 November 2018

Document is current